Tag Archives: Significant

Significant barriers for patients seeking medication for opioid use disorder

Buprenorphine-naloxone (buprenorphine), a highly effective, evidence-based treatment for opioid use disorder (OUD), is difficult to access in states with high rates of death associated with opiates, according to new research led by the Harvard T.H. Chan School of Public Health. The study also found that access to buprenorphine is especially challenging for patients with Medicaid… Read More »